Phase 1 1 trial
Phase 1
NCT07490236 Jan 2023 → Aug 2027 expected —
Hebei Medical University Fourth Hospital
Recruiting
No outcome recorded
Phase 1/2 2 trials
Phase 1/2
NCT02514447 Oct 2015 → Sep 2018 small cell lung carcinoma G1 Therapeutics, Inc.
Completed
No outcome recorded
Phase 1/2
NCT02499770 Jun 2015 → Jul 2017 small cell lung carcinoma G1 Therapeutics, Inc.
Completed
No outcome recorded
Phase 2 33 trials
Phase 2
NCT07255612 Nov → Dec 2026 expected breast cancer Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT07679997 Jun 2026 → Sep 2027 expected head and neck squamous cell carcinoma Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT06992739 Dec 2025 → Mar 2027 expected bone marrow failure syndrome , non-small cell lung carcinoma The First Affiliated Hospital of Xiamen University
Recruiting
No outcome recorded
Phase 2
NCT07160283 Sep 2025 → Sep 2027 expected biliary tract neoplasm , pancreatic neoplasm The Second Affiliated Hospital of Shandong First Medical University
Not yet recruiting
No outcome recorded
Phase 2
NCT06929936 May 2025 → May 2026 overdue myelolymphatic insufficiency , non-small cell lung carcinoma The First Affiliated Hospital of Xiamen University
Recruiting
No outcome recorded
Phase 2
NCT06752798 Dec 2024 → Sep 2025 overdue head and neck squamous cell carcinoma Hunan Cancer Hospital
Recruiting
No outcome recorded
Phase 2
NCT06714266 Dec 2024 → Aug 2026 overdue head and neck squamous cell carcinoma Shandong Cancer Hospital and Institute
Not yet recruiting
No outcome recorded
Phase 2
NCT06714383 Nov 2024 → Jul 2025 overdue conventional osteosarcoma Peking University People's Hospital
Recruiting
No outcome recorded
Phase 2
NCT06699472 Oct 2024 → Sep 2026 expected Ewing sarcoma , chemotherapy-induced toxicity Fudan University
Recruiting
No outcome recorded
Phase 2
NCT06698965 Oct 2024 → Oct 2029 expected small cell lung carcinoma Shanghai Chest Hospital
Recruiting
No outcome recorded
Phase 2
NCT06569459 Jul 2024 → Nov 2025 overdue esophageal squamous cell carcinoma The First Affiliated Hospital with Nanjing Medical University
Recruiting
No outcome recorded
Phase 2
NCT06490081 Jun 2024 → Jan 2026 overdue chemotherapy-induced toxicity Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Recruiting
No outcome recorded
Phase 2
NCT06569485 May → Dec 2024 overdue diffuse large B-cell lymphoma Sun Yat-sen University
Recruiting
No outcome recorded
Phase 2
NCT06370416 Apr 2024 → Jan 2026 overdue non-small cell lung carcinoma Henan Cancer Hospital
Enrolling by invitation
No outcome recorded
Phase 2
NCT06297811 Mar 2024 → Sep 2025 overdue breast cancer , cervical cancer , endometrial cancer , head and neck squamous cell carcinoma +1 Sun Yat-sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT06217003 Feb 2024 → Feb 2025 osteosarcoma The First Affiliated Hospital of Xinxiang Medical College
Unknown
No outcome recorded
Phase 2
NCT06151262 Jan 2024 → May 2025 overdue malignant pancreatic neoplasm The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting
No outcome recorded
Phase 2
NCT06027268 Jan 2024 → Sep 2026 expected triple-negative breast carcinoma Wake Forest University Health Sciences
Active not recruiting
No outcome recorded
Phase 2
NCT05978648 Sep 2023 → Dec 2026 expected breast cancer wang shusen
Recruiting
No outcome recorded
Phase 2
NCT06328049 Aug 2023 → Feb 2025 non-small cell lung carcinoma Taixing People's Hospital
Unknown
No outcome recorded
Phase 2
NCT05862610 Jul 2023 → Dec 2026 expected breast neoplasm Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting
No outcome recorded
Phase 2
NCT06955156 Jul 2023 → May 2025 overdue triple-negative breast carcinoma QIAO LI
Recruiting
No outcome recorded
Phase 2
NCT05910034 Jul 2023 → Dec 2025 non-small cell lung carcinoma Fudan University
Unknown
No outcome recorded
Phase 2
NCT05900921 Jul 2023 → Oct 2024 non-small cell squamous lung carcinoma Sichuan University
Unknown
No outcome recorded
Phase 2
NCT06332287 May 2023 → Nov 2024 non-small cell lung carcinoma Jiangsu Province Nanjing Brain Hospital
Unknown
No outcome recorded
Phase 2
NCT05578326 Oct 2022 → Dec 2026 expected small cell lung carcinoma UNC Lineberger Comprehensive Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT05112536 Mar → Oct 2022 triple-negative breast carcinoma G1 Therapeutics, Inc.
Completed
No outcome recorded
Phase 2
NCT05113966 Dec 2021 → Nov 2023 triple-negative breast carcinoma G1 Therapeutics, Inc.
Terminated
No outcome recorded
Phase 2
NCT04887831 Jun 2021 → Apr 2023 bone marrow failure syndrome , neutropenia , urinary bladder cancer , urothelial carcinoma G1 Therapeutics, Inc.
Terminated
No outcome recorded
Phase 2
NCT04863248 Apr 2021 → Feb 2022 non-small cell lung carcinoma G1 Therapeutics, Inc.
Terminated
No outcome recorded
Phase 2
NCT03041311 Jun 2017 → Aug 2018 small cell lung carcinoma G1 Therapeutics, Inc.
Completed
No outcome recorded
Phase 2
NCT02978716 Feb 2017 → Jun 2019 triple-negative breast carcinoma G1 Therapeutics, Inc.
Terminated
No outcome recorded
Phase 2
NCT01042379 Mar 2010 → Dec 2030 expected HER2 positive breast carcinoma , angiosarcoma , female breast carcinoma , hormone receptor-positive breast cancer +1 QuantumLeap Healthcare Collaborative
Recruiting
No outcome recorded
Show 23 more trials Phase 3 4 trials
Phase 3
NCT07473128 Jun 2026 → Jun 2027 expected small cell lung carcinoma Pharmacosmos A/S
Recruiting
No outcome recorded
Phase 3
NCT06364904 Oct 2025 → Apr 2027 expected urinary bladder cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not yet recruiting
No outcome recorded
Phase 3
NCT04799249 May 2021 → May 2024 triple-negative breast carcinoma G1 Therapeutics, Inc.
Completed
No outcome recorded
Phase 3
NCT04607668 Jan 2021 → Feb 2023 chemotherapy-induced toxicity , colorectal cancer , myeloid hemopathy G1 Therapeutics, Inc.
Terminated
No outcome recorded
Phase 4 2 trials
Phase 4
NCT05874401 Oct 2023 → Oct 2027 expected small cell lung carcinoma Pharmacosmos A/S
Recruiting
No outcome recorded
Phase 4
NCT05071703 Aug 2021 → Apr 2022 small cell lung carcinoma Jiangsu Simcere Pharmaceutical Co., Ltd.
Completed
No outcome recorded
Phase not stated 1 trial
— NCT04504513 — chemotherapy-induced toxicity , myelolymphatic insufficiency , small cell lung carcinoma G1 Therapeutics, Inc.
Approved for marketing
No outcome recorded